Validation of PON1 enzyme activity assays for longitudinal studies. 2009

Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
Center for Children's Environmental Health, School of Public Health, University of California, Berkeley, CA 94720-7360, United States.

BACKGROUND Paraoxonase (PON1) enzymatic activity assays are used to characterize sensitivity to organophosphates and oxidative stress. Length of sample storage, temperature and other factors may influence variability of PON1 measurements, especially in longitudinal studies. METHODS Effects of assay temperature, storage duration up to 7 y (-80 degrees C), freeze-thaw cycles, the type of specimen (serum or heparinized plasma) and assay variability were evaluated for 4 PON1 substrate-specific assays using samples from two pediatric cohorts and laboratory volunteers. RESULTS Intra- and inter-assay variation, as well as inter-laboratory variability for PON1 activities were <10%. The effect of storage duration up to 2 y was minimal. However, after 7 y, arylesterase, paraoxonase, and chlorpyrifos-oxonase activities decreased more noticeably. Similarly, while freeze-thaw cycles did not affect the PON1 activities in samples stored <2 y, this factor was more significant after 7 y for arylesterase. Assay temperature and specimen type also influenced PON1 measurements. CONCLUSIONS Sources of technical variability of PON1 activity assays, including storage duration, freeze-thaw, and temperature should be monitored and minimized through study design, quality control procedures and statistical methods, especially in longitudinal studies where specimens may be stored for years prior to analysis.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010261 Paraoxon An organophosphate cholinesterase inhibitor that is used as a pesticide. Diethyl-p-Nitrophenyl Phosphate,E-600,Fosfakol,Phosphacol,Diethyl p Nitrophenyl Phosphate,E 600,E600,Phosphate, Diethyl-p-Nitrophenyl
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004390 Chlorpyrifos An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide. Dursban,Lorsban
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
October 2009, Environmental health perspectives,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
April 2015, Journal of enzyme inhibition and medicinal chemistry,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
January 2003, Methods in molecular biology (Clifton, N.J.),
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
April 2001, Analytical biochemistry,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
May 2022, Rheumatology (Oxford, England),
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
March 2015, Medical science monitor : international medical journal of experimental and clinical research,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
August 2003, Arteriosclerosis, thrombosis, and vascular biology,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
January 2019, Methods in molecular biology (Clifton, N.J.),
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
December 1999, Veterinary microbiology,
Karen Huen, and Rebecca Richter, and Clement Furlong, and Brenda Eskenazi, and Nina Holland
April 2021, The Journal of veterinary medical science,
Copied contents to your clipboard!